Filtros de búsqueda

Lista de obras de Alessandra Lugaresi

"Nail loss after teriflunomide treatment: A new potential adverse event".

artículo científico publicado en 2017

A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients

artículo científico publicado en 2015

A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples.

artículo científico publicado en 2009

Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine

scientific article published on 01 April 1995

Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1 a antibodies following Campylobacter enteritis

scientific article published on 01 April 1997

Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant

artículo científico publicado en 2003

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

article

Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?

scientific article published on September 2009

Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients ⬇️

artículo científico publicado el 1 de mayo de 1991

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

artículo científico publicado en 2010

An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.

artículo científico publicado en 2015

Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier

artículo científico publicado en 2001

Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

artículo científico publicado en 2018

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

artículo científico publicado en 2017

Anti-sulfatide antibodies in neurological disease: binding to rat dorsal root ganglia neurons

artículo científico publicado en 1992

Anxiety and depression in multiple sclerosis patients around diagnosis

artículo científico publicado en 2011

Apolipoprotein E genotype does not influence the progression of multiple sclerosis

artículo científico publicado en 2003

Arthritic psoriasis during natalizumab treatment: a case report and review of the literature

artículo científico publicado en 2017

Assessing measurement invariance of MSQOL-54 across Italian and English versions

scientific article published on 09 November 2019

Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure

artículo científico publicado en 2015

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

artículo científico publicado en 2018

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

scientific article published on 01 January 2019

Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis

scientific article published on 27 July 2020

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

article

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

artículo científico publicado en 2015

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

artículo científico publicado en 2001

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

artículo científico publicado en 2006

Autonomic failure in a case of Chiari malformation type I.

artículo científico publicado en 1987

Autonomic nervous system function in myotonic dystrophy

artículo científico publicado en 1992

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

artículo científico publicado en 2015

Basal ganglia involvement in multiple sclerosis with alternating side paroxysmal dystonia

scientific article published on 01 January 1993

Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their Caregivers

artículo científico publicado en 2017

CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study

artículo científico publicado en 1991

Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?

artículo científico publicado en 2002

Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy

artículo científico publicado en 1999

Chronic progressive steroid responsive axonal polyneuropathy: A CIDP variant or a primary axonal disorder?

artículo científico publicado en 1996

Circadian Activity Rhythm in Early Relapsing-Remitting Multiple Sclerosis

artículo científico publicado en 2019

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

artículo científico publicado en 2017

Cleavage of cystatin C is not associated with multiple sclerosis

artículo científico publicado en 2007

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

artículo científico publicado en 2019

Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis

scientific article published on 14 October 2020

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

artículo científico publicado en 2006

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom ⬇️

artículo científico publicado en 2022

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

artículo científico publicado en 2016

Comparative efficacy of switching to natalizumab in active multiple sclerosis

artículo científico publicado en 2015

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

scientific article published on 13 January 2019

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

artículo científico publicado en 2015

Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies

scientific article published on 01 June 1993

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany

artículo científico publicado en 2019

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237].

artículo científico publicado en 2017

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

artículo científico publicado en 2012

Decision-Making in Multiple Sclerosis Consultations in Italy: Third Observer and Patient Assessments ⬇️

artículo científico publicado el 2 de abril de 2013

Decreased integrin gene expression in patients with MS responding to interferon-beta treatment

artículo científico publicado en 2004

Defining reliable disability outcomes in multiple sclerosis

artículo científico publicado en 2015

Defining secondary progressive multiple sclerosis

artículo científico publicado en 2016

Delay from treatment start to full effect of immunotherapies for multiple sclerosis

scientific article published on 01 September 2020

Demyelinating motor Guillain-Barre syndrome following rubella

artículo científico publicado en 2005

Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory

artículo científico publicado en 2016

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis

scientific article published on 15 September 2020

Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis

artículo científico publicado en 2020

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

artículo científico publicado en 2016

Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy

artículo científico publicado en 1997

Early clinical markers of aggressive multiple sclerosis

scientific article published on 09 May 2020

Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

scientific article published on 28 December 2020

Effect of oxygen radicals and hyperoxia on rat heart ornithine decarboxylase activity

artículo científico publicado en 1982

Effect of rhTNF-α injection into rat sciatic nerve

artículo científico publicado en 1999

Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.

artículo científico publicado en 2012

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

artículo científico publicado en 2023

Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.

artículo científico publicado en 2013

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

artículo científico publicado en 2012

Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.

artículo científico publicado en 2016

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

article

Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium?

scientific article published on 25 June 2019

Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial

artículo científico publicado en 2011

F response in vascular and degenerative upper motor neuron lesions

artículo científico publicado en 1990

Fingolimod after natalizumab and the risk of short-term relapse

artículo científico publicado en 2014

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

artículo científico publicado en 2015

First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence

artículo científico publicado en 2018

Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block

artículo científico publicado en 1999

Fostering adherence to injectable disease-modifying therapies in multiple sclerosis

artículo científico publicado en 2014

Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31

artículo científico publicado en 2020

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.

artículo científico publicado en 2004

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

artículo científico

Hand dystonia secondary to cervical demyelinating lesion

artículo científico publicado en 1994

Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis

scientific article published on 25 September 2018

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

artículo científico publicado en 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study

artículo científico publicado en 2012

Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial

artículo científico publicado en 2015

How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.

artículo científico publicado en 2015

IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitors

artículo científico publicado en 2004

Identification of glycoconjugates which are targets for anti-Gal(β1-3)GalNAc autoantibodies in spinal motor neurons ⬇️

artículo científico publicado el 1 de octubre de 1991

Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers

artículo científico publicado en 2015

Improving patient-physician dialog: commentary on the results of the MS Choices survey.

artículo científico publicado en 2012

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

scientific article published on 03 January 2019

Increasing age at disability milestones among MS patients in the MSBase Registry

artículo científico

Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra

artículo científico publicado en 2007

Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories

artículo científico publicado en 2016

Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis

scientific article published on 01 December 2005

Interferon beta normalizes suppressor cell function in dysimmune neuropathies

scientific article published on 01 February 1998

Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

scientific article published on 01 February 2002

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?

artículo científico publicado en 2017

Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy

artículo científico publicado el 1 de noviembre de 1992

Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis

artículo científico publicado en 2011

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.

artículo científico publicado en 2016

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

artículo científico publicado en 2017

Low quality of life and psychological wellbeing contrast with moderate perceived burden in carers of people with severe multiple sclerosis

artículo científico publicado en 2016

Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis

artículo científico publicado en 2001

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod

artículo científico publicado en 2017

Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma

artículo científico publicado en 2002

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

artículo científico publicado en 2015

Minimal and asymptomatic chronic inflammatory demyelinating polyneuropathy

artículo científico publicado en 1999

Mononeuropathy following subcutaneous interferon–β injection

artículo científico publicado en 2006

Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis

artículo científico publicado en 2024

Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry

artículo científico publicado en 2015

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

article

Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.

artículo científico publicado en 2015

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients ⬇️

artículo científico publicado en 2011

Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis

artículo científico publicado en 2013

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

artículo científico publicado en 2014

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

artículo científico publicado en 2012

Patient expression of emotions and neurologist responses in first multiple sclerosis consultations

artículo científico publicado en 2015

Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study

artículo científico publicado en 2010

Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons

artículo científico publicado en 1992

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

artículo científico publicado en 2013

Pharmacology and clinical efficacy of dalfampridine for treating multiple sclerosis.

artículo científico publicado en 2014

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

artículo científico publicado en 2009

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

artículo científico publicado en 2014

Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery

artículo científico publicado en 2009

Prediction of on-treatment disability worsening in RRMS with the MAGNIMS score

artículo científico publicado en 2020

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

artículo científico publicado en 2013

Predictors of disability worsening in clinically isolated syndrome.

artículo científico publicado en 2015

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

artículo científico publicado en 2016

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy

Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy

artículo científico publicado en 1999

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

artículo científico publicado en 2012

Prognostic indicators in pediatric clinically isolated syndrome

artículo científico publicado en 2017

Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry

artículo científico publicado en 2010

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

artículo científico publicado en 2016

RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b

artículo científico publicado en 2000

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

artículo científico publicado en 2009

RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence

artículo científico publicado en 2012

Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery

artículo científico publicado en 1990

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

scientific article published on 31 October 2019

Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone).

artículo científico publicado en 2008

Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients

artículo científico publicado en 2012

Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]

scientific article published on 24 February 2018

Risk attitude and personality in people with multiple sclerosis facing the choice of different disease-modifying therapy scenarios

artículo científico publicado en 2020

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

artículo científico publicado en 2016

Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study

artículo científico publicado en 2013

Risk of relapse phenotype recurrence in multiple sclerosis.

artículo científico publicado en 2014

Risk of secondary progressive multiple sclerosis: A longitudinal study

scientific article published on 09 August 2019

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis ⬇️

artículo científico publicado el 24 de junio de 2013

Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study

artículo científico publicado en 2008

Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy

artículo científico publicado en 2016

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

artículo científico publicado en 2014

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

artículo científico publicado en 2014

Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica

artículo científico publicado en 2011

Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study.

artículo científico publicado en 1990

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

artículo científico publicado en 2013

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

scientific article published on 20 September 2018

Sleep-related disorders and their relationship with MRI findings in multiple sclerosis

artículo científico publicado en 2019

Steroid-responsive multifocal demyelinating neuropathy with central involvement

artículo científico publicado en 1999

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis

artículo científico publicado en 2015

Sympathetic skin response in hemispheric lesions

artículo científico publicado en 1992

Teeth loss after teriflunomide treatment: Casual or causal? A short case series

artículo científico publicado en 2018

Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship

artículo científico publicado en 2018

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population

artículo científico publicado en 2014

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy

artículo científico publicado en 2004

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.

artículo científico publicado en 2016

The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.

artículo científico publicado en 2013

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

artículo científico publicado en 2015

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

artículo científico publicado en 2020

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

artículo científico publicado en 2017

Transdermal scopolamine cycloplegia in juvenile diabetes

scientific article published on 01 April 1989

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

artículo científico publicado en 2020

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

artículo científico publicado en 2017

Treatment response score to glatiramer acetate or interferon beta-1a

artículo científico publicado en 2020

Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention

artículo científico publicado en 2014

Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

artículo científico publicado en 2016

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda